Notice is hereby given in accordance with § 2.2-4007.01 of the Code of Virginia that the Board of Medicine intends to consider promulgating 18VAC85-21, Regulations Governing Prescribing of Opioids and Buprenorphine. The purpose of the proposed action is to respond to a public health emergency in deaths from overdoses and Chapter 291 of the 2017 Acts of Assembly, which mandates promulgation of regulations for prescribing of opioids and buprenorphine.

The agency intends to hold a public hearing on the proposed action after publication in the Virginia Register.

Statutory Authority: §§ 54.1-2400 and 54.1-2928.2 of the Code of Virginia.

Public Comment Deadline: May 3, 2017.

Agency Contact: William L. Harp, M.D., Executive Director, Board of Medicine, 9960 Mayland Drive, Suite 300, Richmond, VA 23233, telephone (804) 367-4558, FAX (804) 527-4429, or email william.harp@dhp.virginia.gov.

Notice is hereby given in accordance with § 2.2-4007.01 of the Code of Virginia that the Board of Pharmacy has WITHDRAWN the Notice of Intended Regulatory Action (NOIRA) for 18VAC110-20, Regulations Governing the Practice of Pharmacy, which was published in 26:4 VA.R. 339 October 26, 2009. The NOIRA is unnecessary as the agency proceeded with this regulatory action through the fast-track rulemaking process under § 2.2-4012.1 of the Code of Virginia. The fast-track rulemaking action was published in 27:11 VA.R. 1194-1196 January 31, 2011.

Agency Contact: Caroline Juran, RPh, Executive Director, Board of Pharmacy, 9960 Mayland Drive, Suite 300, Richmond, VA 23233-1463, telephone (804) 367-4416, FAX (804) 527-4472, or email caroline.juran@dhp.virginia.gov.